GlassScriptPhysician profile
Peter J Jones
NPI 1164518908
$1,769.19
in general payments reported to CMS, 2019-2025
15 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.72 · 2020: $280 · 2021: $202 · 2022: $63.52 · 2023: $117 · 2024: $644 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $766.72 | 2019-2025 | Axonics, Lithoclast, Spaceoar Vue System - 10ml |
| Medtronic, INC. | $380.28 | 2021-2025 | Interstim, Altaviva |
| Teleflex LLC | $179.03 | 2024 | Urolift |
| Astellas Pharma US INC | $114.89 | 2025 | Padcev |
| Intuitive Surgical, INC. | $96.02 | 2023 | Da Vinci Surgical System |
| Medtronic USA, INC. | $90.08 | 2019-2020 | |
| Calyxo, INC. | $24.22 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $22.07 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $19.69 | 2024 | Gemtesa |
| 180 Medical, INC. | $18.36 | 2024 | Gentlecath |
| Axonics, INC. | $16.93 | 2024 | Axonics |
| Coloplast Corp | $16.06 | 2024 | |
| Therapeuticsmd, INC. | $13.14 | 2019 | |
| Ambu INC. | $6.62 | 2024 | |
| Travere Therapeutics, INC. | $5.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.